An interventional study of Intensive monioring group and Standard monitoring group in Hernioplasty, Cholecystectomy, Laparoscopic and Haemorrhoidal Surgery, sponsored by Consorci Sanitari del Maresme. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-05.
Sponsored by Consorci Sanitari del Maresme · Not applicable, Interventional, and Treatment
Among 341 studies in Pain with a site in Spain — 58 open to participants now, 68 under way, 7 of them phase 3. Pain · Spain.
Among the 341 studies in Pain with a site in Spain, this one is the 39th largest by enrollment of the 295 interventional ones that give a count, is one of 24 that started in 2025, is one of 206 with no phase, and was the 313th registered.
10,060 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →58 of the 341 studies in Pain with a site in Spain are open now. Recruiting first, the newest first:
Neuron, Spain · Sites in Spain
Ages 18+ · Healthy volunteers
University Rovira i Virgili · Sites in Spain
Ages 18–40 · Healthy volunteers
European University Miguel de Cervantes · Sites in Spain
Ages 18+ · Women only
Institut Investigacio Sanitaria Pere Virgili · Sites in Spain
Ages 18–50 · Women only
Arafarma Group, S.A. · Sites in Spain
Ages 18+ · Women only
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 929 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
341 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 29 · Phase 3 47 · Phase 4 17
First in 2001; this study’s year is marked. 24 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 280 is above the median of 66 across 8,497 interventional studies indexed under Pain.
Median enrollment 60 across the 295 interventional studies, 165 across the 46 observational. Of the 245 that completed or were terminated, 37 (15%) have results posted.
This tab as a report to print or save as PDF → With an account.
72 of 341 have an industry lead sponsor. The 10 most frequent:
Consorci Sanitari del Maresme is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
Consorci Sanitari del Maresme has 1 study filed under Pain — fewer than ten, so there is no comparison to draw.
7 of the studies in Pain with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04299893Phase 3Bernardino Clavo, MD, PhDOzone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) | 2027-09-30 |
| NCT06948500Cardenal Herrera UniversityEffectiveness of an IVR-based Therapeutic Exercise Program With Altered Visual Feedback in Fibromyalgia Patients | 2026-12-01 |
| NCT07694141Hospital Universitario de Gran Canaria Doctor NegrínPostoperative Analgesia in Thoracic Surgery | 2026-12-31 |
| NCT05635929Mucosa Innovations, S.L.Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs. | 2027-03 |
| NCT07741864Hospital Universitario Virgen MacarenaEffectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis (MPIMS). | 2027-04-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 341 studies in Pain with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Moderate to severe acute postoperative pain (APP) during part of the postoperative period is a barrier that hinders the central objective of perioperative medicine, which is to achieve an optimal postoperative recovery process. Despite advances in perioperative medicine, a large proportion of post-operative patients continue to suffer from moderate to severe APS during many of the days of their convalescence. This poor control of APS, in addition to causing suffering and exposing the patient to an increased risk of complications, could impair the quality of post-surgical recovery , according to some authors. We therefore consider it to be of utmost interest in our field to corroborate whether the implementation of measures to better control DAP is related to a better quality of post-surgical recovery.
Currently, the growing trend to take into account the perspective of patients in their care has prompted the development of various patient-centred measurement tools that, among other aspects, assess the quality of post-surgical recovery. Several scales have been designed. The most widely used are the QoR-40, QoR-9 and QoR-15 scales. The latter, with a range of 0 to 150, was developed to simplify assessment, especially in telephone follow-ups, and has a reliability similar to its predecessor, the QoR-40.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Routine follow-up (telephone call on the morning after surgery)
Other: Standard monitoring group
Routine follow-up (telephone call on the morning after surgery) and Intensive follow-up of acute post-surgery pain.
Other: Intensive monioring group
Routine follow-up (telephone call on the morning after surgery) and Intensive follow-up of acute post-surgery pain (telephone call every day since pain resolution).
Routine follow-up (telephone call on the morning after surgery).
Quality of Recovery
Quality of Recovery (QoR15 test)
Time frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Pain Control by Visual Analogic Scale
Visual Analogic Scale of pain. Range values: 0 (minium pain) thru 10 (maximum pain)
Time frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Satisfaction of pain control
A 4-level Likert scale will be used according to the patient's criteria: dissatisfied, slightly dissatisfied, fairly satisfied, completely satisfied.
Time frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Adherence to prescribed analgesic treatment
4-level Likert scale according to the patient's criteria: no adherence, low adherence, moderate adherence, and total adherence.
Time frame: Baseline (pre-surgery) and 48 hours, 7 days and 14 days post-surgery
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2025 to primary completion in Aug 2025, 5 months.
Of 3,734 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 5 months is below that.
Counting every sponsor, half of 3,833 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Consorci Sanitari del Maresme